Cancer tumor nomenclature

T9. Triolo, V. A., Nineteenth century foundation of cancer research advances in tumor pathology, nomenclature, and theories of oncogenesis. Cancer Res. 25, 75—106 (1965). 

The histological classification of thyroid tumors following the World Health Organization nomenclature (DeLellis et al.y 2004) is shown in Table 53.1. Thyroid cancers that were shown to change their incidence after iodine prophylaxis... 

Budotitane ([Ti(bzac)2(OEt)2] bzac = l-phenylbutane-l,3-dionate, OEt = ethoxide) is a possible anti-cancer drug which has shown promising results in preclinical tests [320], although to date little objective tumor response in humans (clinical Phase I studies) has been observed [321]. There are five possible isomers (Table 8.4), the nomenclature of which is as follows the first cis/trans prefix refers to the relative positions of the X ligands (ethanolate) the second to the relative orientation of the benzoyl groups and the third to the relative orientation of the acetyl moieties of the benzoylacetonate ligands. 

---